
STADA Arzneimittel AG
Bad Vilbel
Official notice
to holders of warrants
issued by our company
(SIN 725 184 // ISIN DE0007251845)
and
to holders of bearer bonds with warrants attached
(SIN 106 954 // ISIN DE0001069540)
(This is a non-binding translation of the original German version.)
Following the decision by STADA Arzneimittel AG on September 22, 2003 to launch a rights issue granting pre-emption rights to existing shareholders, the terms and conditions governing the company's warrants are to be amended as follows for the above securities pursuant to § 7 (1) a of the terms and conditions governing warrants with effect from October 14, 2003:
The strike price - adjusted to EUR 30.00 with effect from October 2, 2000 in the official notice of September 2000 (§ 1 (2) sentence 2 of the terms and conditions governing warrants) - now amounts to EUR 27.90. The premium payable for a warrant entitling the holder to subscribe for 10 shares of STADA Arzneimittel Aktiengesellschaft (§ 1 (2) sentence 1 of the terms and conditions governing warrants) now amounts to EUR 329.00 instead of EUR 350.00. The reduced premium payable for a warrant entitling the holder to subscribe for 10 shares of STADA Arzneimittel AG (§ 1 (2) sentence 2 of the terms and conditions governing warrants) amounts to EUR 279.00. The other terms and conditions remain unchanged.
Bad Vilbel, October 2003
STADA Arzneimittel AG
The Executive Board